Related Experiment Videos

Relationships among changes in C-reactive protein and cardiovascular disease risk factors with lifestyle

D Young1, S Camhi, T Wu

  • 1Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, USA.

Insights

Lifestyle interventions like diet and exercise may independently influence C-reactive protein (CRP) levels, an inflammation marker, in individuals with dyslipidemia. These changes appear separate from traditional cardiovascular disease risk factors.

Area of Science:

  • Cardiovascular Disease Research
  • Inflammation and Metabolism
  • Lifestyle Interventions

Background:

  • Inflammation is implicated in cardiovascular disease (CVD) development.
  • Elevated C-reactive protein (CRP) is an emerging CVD risk factor.
  • CRP is associated with traditional CVD risk factors.

Purpose of the Study:

  • To examine changes in CRP and CVD risk factors after one-year diet and physical activity interventions.
  • To determine if CRP changes concurrently with other risk factors or independently.

Main Methods:

  • Secondary data analysis of 143 men and 133 women with dyslipidemia.
  • Randomized to low-fat diet, physical activity, combined, or control groups for one year.
  • Assessed changes in CRP, lipids, glucose, insulin, blood pressure, and waist circumference using regression models.

Main Results:

  • CRP change was negatively associated with triglyceride change in both sexes.
  • CRP change was positively associated with systolic blood pressure change in men.
  • CRP change was not associated with other traditional CVD risk factors.

Conclusions:

  • Dietary and/or physical activity-induced changes in CRP may be largely independent of traditional CVD risk factors.
  • Findings suggest lifestyle interventions can impact CRP levels distinctly from other risk factors in dyslipidemia patients.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...